Showing 22,152 results

Filters Content type: Editors' picks
Religion & faith

Swaziland: Thabile Xaba, 'I Can Take the ARVs Now if I Like But I Must Consult the Ancestors'

Editor's pick
IRIN Plus News
2 March 2011
Men who have sex with men (MSM)

New Report: World's Premier AIDS Event Neglects Populations Most at Risk for HIV

Editor's pick
CNBC
2 March 2011
UK health services

UK: NHS reform could see GP surgeries on stock market

Editor's pick
The Guardian
2 March 2011
Epidemiology

Thousands of people with HIV protest India-EU trade deal restricting access to cheap drugs

Editor's pick
Los Angeles Times
2 March 2011
Epidemiology

Thousands of people with HIV protest India-EU trade deal restricting access to cheap drugs

Editor's pick
2 March 2011
New & experimental HIV treatments

Virostatics' VS411 Phase 2a trial results against HIV presented at 18th CROI

Editor's pick
The Medical News
2 March 2011
New & experimental HIV treatments

Tobira reports on PK, safety, of new CCR5 inhibitor cenicriviroc

Editor's pick
Bioportfolio
2 March 2011
New & experimental HIV treatments

Recombinant Interleukin-7 (CYT107) Expands CD4 T-Cells In Gut Mucosa Of Chronically HIV Infected Immunological Non-Responder Patients

Editor's pick
HIV / AIDS News From Medical News Today
2 March 2011
How HIV works

NIH-funded study shows early brain effects of HIV in mouse model

Editor's pick
EurekAlert
2 March 2011
Adherence

Intensive adherence counseling with HIV treatment improves patient outcomes

Editor's pick
Eurekalert HIV
1 March 2011
Treatment for women

Studies in Post-Menopausal Women Reveal Potentially Higher Biological HIV Risk, as Well as Possible Tenofovir Concerns

Editor's pick
The BodyPro
1 March 2011
Neurological & cognitive problems

Previous Syphilis Infection Might Cause Poorer Brain Function for People With HIV

Editor's pick
AIDSmeds.com
1 March 2011
Starting treatment

3-year results on Merck’s ISENTRESS® (raltegravir): sustained viral load suppression and tolerability

Editor's pick
Business Week
1 March 2011
Finance & funding

Winners and losers in the UK aid review

Editor's pick
The Guardian
1 March 2011
HIV treatment

Glaxo Seeks $1.5 Billion in AIDS Drug Trial Against Abbott

Editor's pick
Bloomberg
1 March 2011
Finance & funding

UK aid budget refocuses 'on areas of greatest need'

Editor's pick
The Guardian
1 March 2011
Treatment outcomes & life expectancy

Risk of Virologic Failure 40 Percent Higher Among Blacks vs. Whites

Editor's pick
AIDSMeds
1 March 2011
Ethnic & cultural minorities

Risk of Virologic Failure 40 Percent Higher Among Blacks vs. Whites

Editor's pick
Kaiser Daily Global Health Policy Report
1 March 2011
Pregnancy and vertical transmission

Uganda: Cash Crunch Delays Shift to WHO-Recommended PMTCT Regimen

Editor's pick
IRIN Plus News
28 February 2011
PrEP

Gilead's $12000-a-Year HIV Prevention Pill Fails to Win Physician Support

Editor's pick
Bloomberg
28 February 2011
PrEP

Gilead's $12000-a-Year HIV Prevention Pill Fails to Win Physician Support

Editor's pick
28 February 2011
Epidemiology

Zimbabwe: Who Should Have Access to Free ARVs?

Editor's pick
AllAfrica
28 February 2011
PrEP

Concept paper on medicines to prevent HIV infection released for public consultation

Editor's pick
European Medicines Agency
27 February 2011
Epidemiology

Other routes to HIV drug assistance

Editor's pick
Los Angeles Times
26 February 2011